Press and Media

Reporting on the future of cancer care.

Mount Sinai

Vivan Therapeutics Secures Expanded Drug Discovery & Development Platform From Mount Sinai Health System in New York

 

24 May 2021
New personalised therapeutics partner joins Repositive Cancer Model network

 

2 March 2021

Could Fruit Flies Help Match Patients With Cancer Treatments?

 

26 Feb 2021

Medicision reaches deal to provide avatar-driven precision cancer treatment

 

16 September 2020
Midicision
Medivizor Logo

My Personal Therapeutics and Medivizor Announce a Collaboration Agreement

31 August 2020

My Personal Therapeutics to Test Fruit Fly Avatar Technology in Gastrointestinal
Cancer Patients

 

24 July 2020
Precision Logo
Acindes Logo

My Personal Therapeutics awarded grant from Innovate UK to collaborate with the NIHR – London In Vitro Diagnostic Co-operative to provide personalised treatment to patients with Gastro-Intestinal Cancer

15 July 2020

My Personal Therapeutics and Pentavere scoop funding for lung cancer digital therapeutics

 

3 July 2020
Acindes Logo

My Personal Therapeutics and Acindes announce an exclusive collaboration agreement

27 April 2020

GHP News 2020 Biotechnology Awards Winners

 

14 April 2020
biotech

Building avatar armies with fish and flies

24 March 2020

Silicon Valley pone en su podio a My Personal Therapeutics: tratamiento de cáncer personalizado

 

9 March 2020
Alicante Plaza Logo
myTomorrows Collaborates with My Personal Therapeutics

19 February 2020

 

7 February 2020
A personal “flybrary”

27 January 2020

 

25 November 2019
Forbes Logo

 

13 September 2019

Are fruit fly ‘avatars’ the next step in personalized medicine?

24 May 2019

 22 May 2019

News Scientist Logo
10 to Watch: Up-and-Coming Companies Fulfilling the Promise of Precision Medicine

22 May 2019

 

22 May 2019

 

30 April 2019
Mount Sinai

Order now or contact us to learn more